---
$id: https://graph.org.ai/products/commodity/51372101
$type: Product
source: UNSPSC
code: "51372101"
title: "Acetyldihydrocodeine"
class: "51372100"
classTitle: "Controlled substance analgesic morphine derivatives"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Acetyldihydrocodeine

**UNSPSC Code**: 51372101
**Class**: [Controlled substance analgesic morphine derivatives](Controlled substance analgesic morphine derivatives.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist with the molecular formula C20H25NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SGY1T84P34, chemically known as 7,8-dihydrocodeine acetate but generally known as acetyldihydrocodeine, which bears US NIH Compound Identifier 5463874. European Medicines Agency schedules Acetyldihydrocodeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12719MIG. World Health Organization schedules acetyldihydrocodeine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule acetyldihydrocodeine under HS 29391900 and SITC 54141. As of Q4 2014, ACETYLDIHYDROCODEINE remains the US FDA Preferred Term for this commodity. SMILES: O1C2C34C(C(N(CC3)C)CC3C4C1C(OC)CC3)CCC2OC(=O)C.

